D-0514-2019 Class III Terminated

Recalled by ACP Nimble Buyer, Inc. — South Plainfield, NJ

FDA drug recall D-0514-2019 was initiated by ACP Nimble Buyer, Inc. on Feb 7, 2019 and is designated Class III. Reason for recall: Labeling: Not Elsewhere Classified. Mometasone Furoate Cream has an NDC typographical error. The recall status is terminated (terminated Mar 23, 2020). Affected quantity: 58,176 units.

Recall details

Product Type
Drugs
Report Date
Feb 27, 2019
Initiation Date
Feb 7, 2019
Termination Date
Mar 23, 2020
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
58,176 units

Product description

Mometasone Furoate Cream, 0.1%, 45 g tube, Rx Only, Manufactured by: G&W Laboratories, Inc. South Plainfield, NJ 07080, NDC 0713-0726-37

Reason for recall

Labeling: Not Elsewhere Classified. Mometasone Furoate Cream has an NDC typographical error.

Distribution pattern

Nationwide within the United States

Code information

Lot #: 1009431, 1009507, Exp. 08/2020; 1009886, Exp. 09/2020

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0514-2019
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0514-2019. Report a data issue: hello@regdatalab.com.